peroxynitrous acid has been researched along with dinoprostone in 13 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | peroxynitrous acid (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (92.31) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, KE; Resta-Lenert, S | 1 |
| Fakhrzadeh, L; Laskin, DL; Laskin, JD | 1 |
| Beharka, AA; Meydani, SN; Serafini, M; Wu, D | 1 |
| Beall, HD; Bunderson, M; Coffin, JD | 1 |
| Deby-Dupont, G; Devel, P; Henrotin, Y; Martin, G; Mathy-Hartert, M; Pujol, JP; Reginster, JY | 1 |
| Deeb, RS; Gamss, C; Hajjar, DP; Lindenbaum, R; Mittar, D; Resnick, MJ; Upmacis, RK | 1 |
| Migita, K | 1 |
| Armstrong, JS; Schantz, JT; Spencer, JP; Whiteman, M; Zhu, YZ | 1 |
| Hwang, HJ; Kang, KJ; Lee, BH; Shin, HC | 1 |
| Bachschmid, MM; Clavreul, N; Cohen, RA; Hou, X; Ido, Y; Idrizovic, A; Pimentel, D; Shi, C | 1 |
| Hong, DH; Hwang, HJ; Kang, K; Kim, SH; Lee, BH; Park, Y; Shin, HC | 1 |
| Cantoni, O; Cerioni, L; Palomba, L; Tommasini, I | 1 |
| Chen, YJ; Quilley, J; Santos, M | 1 |
1 review(s) available for peroxynitrous acid and dinoprostone
| Article | Year |
|---|---|
[Nitric oxide in rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Cyclooxygenase 2; Dinoprostone; Gene Expression Regulation, Enzymologic; Humans; Matrix Metalloproteinase 2; Membrane Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Prostaglandin-Endoperoxide Synthases; Synovial Membrane | 2005 |
12 other study(ies) available for peroxynitrous acid and dinoprostone
| Article | Year |
|---|---|
Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Biological Transport; Caco-2 Cells; Chlorides; Cyclic AMP; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Dinoprostone; Electric Impedance; Enzyme Inhibitors; Epithelial Cells; Escherichia coli Infections; Gene Expression Regulation, Enzymologic; Guanylate Cyclase; HT29 Cells; Humans; Intestinal Mucosa; Isoenzymes; Membrane Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Peroxynitrous Acid; Prostaglandin-Endoperoxide Synthases; Salmonella Infections; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Sulfonamides; Up-Regulation; Water-Electrolyte Balance | 2002 |
Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury.
Topics: Administration, Inhalation; Animals; Bronchoalveolar Lavage Fluid; Cells, Cultured; Dinoprostone; Female; Interferon-gamma; Lipopolysaccharides; Lung; Macrophages, Alveolar; Mice; Mice, Inbred Strains; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidants, Photochemical; Ozone; Peroxynitrous Acid; Pneumonia; Superoxides; Tyrosine | 2002 |
Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: role of peroxynitrite.
Topics: Aging; Animals; Antioxidants; Cyclooxygenase 2; Dinoprostone; Isoenzymes; Macrophages; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Peroxynitrous Acid; Prostaglandin-Endoperoxide Synthases; Superoxides; Vitamin E | 2002 |
Arsenic induces peroxynitrite generation and cyclooxygenase-2 protein expression in aortic endothelial cells: possible role in atherosclerosis.
Topics: Animals; Aorta; Arsenic; Arteriosclerosis; Cattle; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Endothelium; Gene Expression Regulation, Enzymologic; Isoenzymes; Peroxynitrous Acid; Prostaglandin-Endoperoxide Synthases | 2002 |
Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes.
Topics: Cartilage, Articular; Cell Survival; Chondrocytes; Dinoprostone; DNA; DNA Fragmentation; Down-Regulation; Humans; In Vitro Techniques; Inflammation; Interleukin-1; Interleukin-6; Interleukin-8; L-Lactate Dehydrogenase; Lipopolysaccharides; Nitric Oxide; Osteoarthritis; Peroxynitrous Acid; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells.
Topics: Animals; Arachidonic Acid; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Chelating Agents; Dinoprostone; Enzyme Inhibitors; Group IV Phospholipases A2; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Molsidomine; Muscle, Smooth, Vascular; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Peroxynitrous Acid; Phospholipases A; Rats | 2004 |
Peroxynitrite-modified collagen-II induces p38/ERK and NF-kappaB-dependent synthesis of prostaglandin E2 and nitric oxide in chondrogenically differentiated mesenchymal progenitor cells.
Topics: Arthritis; Cell Differentiation; Cells, Cultured; Collagen Type II; Cyclooxygenase 2; Dinoprostone; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Membrane Proteins; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Peroxynitrous Acid; Phosphorylation | 2006 |
An antioxidative and antiinflammatory agent for potential treatment of osteoarthritis from Ecklonia cava.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cartilage, Articular; Cell Line; Dinoprostone; Free Radical Scavengers; Lipopolysaccharides; Lipoproteins, LDL; Macrophages; Mice; Osteoarthritis; Peroxynitrous Acid; Phaeophyceae; Proteoglycans; Rabbits; Seaweed; Tannins | 2006 |
S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein.
Topics: Alprostadil; Animals; Aorta; Cattle; Dinoprostone; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glutathione; Glutathione Disulfide; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipoproteins, LDL; Lysophosphatidylcholines; Oncogene Protein p21(ras); Oxidants; Peroxynitrous Acid; Phosphoproteins; Phosphorylation; Prostaglandins E, Synthetic; Signal Transduction | 2006 |
Antioxidant and antiinflammatory activities of ventol, a phlorotannin-rich natural agent derived from Ecklonia cava, and its effect on proteoglycan degradation in cartilage explant culture.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cartilage, Articular; Cell Line; Culture Media; Dinoprostone; Dioxins; Dose-Response Relationship, Drug; Free Radical Scavengers; Glycosaminoglycans; Humans; Interleukin-1alpha; Lipoproteins, LDL; Macrophages, Peritoneal; Mice; Molecular Structure; Organ Culture Techniques; Oxidation-Reduction; Peroxynitrous Acid; Phaeophyceae; Phenols; Proteoglycans; Rabbits; Recombinant Proteins | 2004 |
Prostaglandin E2 signals monocyte/macrophage survival to peroxynitrite via protein kinase A converging in bad phosphorylation with the protein kinase C alpha-dependent pathway driven by 5-hydroxyeicosatetraenoic acid.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; bcl-Associated Death Protein; Cell Death; Cell Survival; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Enzyme Activation; Humans; Hydroxyeicosatetraenoic Acids; Inflammation; Macrophages, Peritoneal; Mitochondrial Proteins; Monocytes; Peroxynitrous Acid; Phospholipase A2 Inhibitors; Phospholipases A2; Phosphorylation; Protein Kinase C-alpha; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; U937 Cells | 2008 |
Treatment of diabetic rats with a peroxynitrite decomposition catalyst prevents induction of renal COX-2.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Cells, Cultured; Creatinine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Experimental; Dinoprostone; Humans; Kidney; Male; Metalloporphyrins; Peroxynitrous Acid; Rats; Rats, Wistar; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Tyrosine | 2011 |